Navigation Links
Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
Date:1/12/2009

pany has completed the animal studies necessary to demonstrate the efficacy of ABthrax, the human safety studies necessary for approval, and the manufacture of all bulk drug necessary to supply 20,000 doses of ABthrax to the Stockpile. In May 2008, HGS submitted the final data package to the FDA to support authorization of delivery. ABthrax is being developed under a contract with the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Department of Health and Human Services (HHS).

"We believe that ABthrax offers a significant step forward in the treatment of inhalation anthrax and could play an important role in strengthening America's arsenal against bioterrorism," said Mr. Watkins. "We expect to receive authorization to begin delivery to the Strategic National Stockpile early this year. We are confident that we will receive at least $150 million in 2009 from our $165 million contract with the U.S. Government."

Key goals for ABthrax in 2009:

  • Deliver 20,000 doses of ABthrax to the Strategic National Stockpile early in 2009.
  • Receive at least $150 million in revenue.
  • File a Biologics License Application with the FDA in the second quarter.

Darapladib: GSK Phase 3 Development Program Underway

In December 2008, GSK announced initiation of the first pivotal Phase 3 clinical trial to evaluate the efficacy of long-term treatment with the investigational Lp-PLA2 inhibitor darapladib in men and women with chronic coronary heart disease. Darapladib was discovered by GSK based on HGS technology. HGS will receive 10% royalties on worldwide sales if darapladib is commercialized, and has a 20% co-promotion option in North America and Europe.

In its announcement, GSK said, "Despite major advances in medical treatment, coronary heart disease remains the leading cause
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... July 6, 2015   BioClinica®, Inc ., ... today announced that it has acquired a leading ... , Inc. (Medici).  The acquisition includes affiliates ... Medici also provides a lost-to-follow-up patient locate service ...  Together with Medici, BioClinica will offer ...
(Date:7/6/2015)... 2015 Cardinal Health today announced the completion ... distributor of generic pharmaceuticals, over-the-counter medications and related products ... owned by Court Square Capital Partners. The $1.115 billion ... new debt.  Headquartered in ... revenues of approximately $450 million in 2014. There are ...
(Date:7/6/2015)... , July 6, 2015 E-QURE Corp (OTCQB: ... present live at VirtualInvestorConferences.com on July 9, 2015. ... http://tinyurl.com/e-qure-presentation This will be ... to ask the company questions in real-time - both ... "virtual trade booth." If attendees are not able to ...
Breaking Medicine Technology:BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 2Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 3E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2
... Ga., June 14, 2011 Cardinal Health today opened ... further expanding its nationwide capability to manufacture molecular imaging ... treatment of cancer, neurological disorders and heart disease. ... Positron Emission Tomography (PET) molecular imaging agents, one of ...
... June 14, 2011 Orthopedics This Week announced today ... News to supply Orthopedics This Week, the #1 source ... terminal subscribers including some of the most prominent investors ... The Bloomberg network includes portfolio managers, central bankers, finance ...
Cached Medicine Technology:Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia 2Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia 3Orthopedics This Week Now on Bloomberg 2
(Date:7/6/2015)... Beach, Virginia (PRWEB) , ... July 06, 2015 ... ... States choose fat-reduction procedures each year for aesthetic reasons, which is why liposuction ... country. For a particular demographic, however, fat reduction has become more than a ...
(Date:7/6/2015)... ... July 06, 2015 , ... Longevity, the highest ... with Woodbridge Walk-In Urgent Care to offer on-site health screenings. These ultrasound screenings ... Screenings are affordable and accurate and run about an hour long with same ...
(Date:7/6/2015)... ... , ... MD Now, the leading and fastest-growing urgent care provider in Florida, ... will serve residents and visitors in the Cutler Bay area, giving them convenient access ... location, the new facility will be the fourth to serve Miami-Dade County. Located at ...
(Date:7/6/2015)... ... July 06, 2015 , ... Dr. Lawrence Green is now offering the ... Kybella is a non-surgical method to dissolve fat cells and is the first ... fat deposits under the chin, commonly known as a double chin. Dr. Green participated ...
(Date:7/6/2015)... , ... July 06, 2015 , ... The Path of ... into the economic transformation associated with the U.S. economy over the past 40 years. ... with its use. In many ways, the book is a time capsule that chronicles ...
Breaking Medicine News(10 mins):Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 3Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2
... declared as Breast Cancer Awareness Month and with that ... shops//. The campaign for raising funds towards breast ... cosmetics and teddy bears, as well as major charity ... ,The Boobie-Thon that has been running annually for ...
... Access to treatments for cancer, such as radiotherapy, surgery ... drugs and medical training// vary throughout the EU, according ... Medical Oncology (ESMO) on 3 October 2006. Access to ... country. ,The survey published in Medical OncologyStatus ...
... have been graded as unpleasant or very unpleasant by 56% ... Mind revealed that 29% of them expressed dissatisfaction over the ... satisfied with the standards of hygiene.,Mind is for patients to ... may be slowed down by frustration due to boredom caused ...
... flawed perception in the mind concerning an indefinable ethereal ... , , ... the former president of Society of Nuclear Medicine(SNM), who has ... Nuclear Medicine, regarding understanding radiological and nuclear terrorism ," "Say the ...
... Americans have been trying to get their cholesterol levels down ... high cholesterol and heart disease//. But in recent years, experts ... recommending very low levels of the type of cholesterol called ... means they had to take multiple medications to get there. ...
... 4.5 pounds) at birth and are not disabled are ... physical and mental difficulties, according to a report in ... Medicine, one of the JAMA/Archives journals. ,Low birth ... disabilities such as cerebral palsy and mental retardation, but ...
Cached Medicine News:Health News:All in the Name of ‘Breast Cancer Awareness 2Health News:Mental Health Wards rated unpleasant 2Health News:"New" Clear Advantages In Nuclear Medicine 2Health News:No Clear Evidence for Ultra-Low Cholesterol Targets? 2Health News:No Clear Evidence for Ultra-Low Cholesterol Targets? 3Health News:No Clear Evidence for Ultra-Low Cholesterol Targets? 4Health News:Low Birth Weight Babies May Have Mental & Physical Problems 2
... implant is a combination of innovative design, ... makes TheraSeed® treatment an ideal choice for ... that every TheraSeed® implant order is backed ... required by clinicians who must meet the ...
ACMI™ Double-J Closed Tip Ureteral Stents feature patented dual durometer thermosensitive Tecoflex® construction for physician ease of placement and patient comfort....
Used for retrograde positioning of a ureteral stent. The radiopaque band improves fluoroscopic visibility of the positioner tip. Supplied sterile in peel-open packages. Intended for one-time use....
... for interoperative placement to stent ... construction and continent urinary diversions. ... Intended for one-time use. CAUTION: ... must not remain indwelling more ...
Medicine Products: